The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.

To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attrition among presumptive and confirmed Multi-Drug Resistant Tuberculosis (MDR-TB) patients and ii) factors associated with attrition.This was a retrospective cohort study involving record review. Presumptive MDR-TB patients from peripheral microscopy centres serving 60% of the total population of Bangladesh were included in the study. Attrition and turnaround time for MDR-TB diagnosis by Xpert MTB/RIF and treatment initiation were calculated between July 2012 and June 2014.Of 836 presumptive MDR-TB patients referred from 398 peripheral microscopy centres, 161 MDR-TB patients were diagnosed. The number of diagnosed MDR-TB patients was less than country estimates of MDR-TB patients (2000 cases) during the study period. Among those referred, pre-diagnosis and pre-treatment attrition was 17% and 21% respectively. Median turnaround time for MDR-TB testing, result receipt and treatment initiation was four, zero and five days respectively. Farmers (RR=2.3, p=0.01) and daily wage laborers (RR=2.1, p=0.04) had twice the risk of having pre-diagnosis attrition. Poor record-keeping and unreliable upkeep of presumptive MDR-TB patient databases were identified as challenges at the peripheral microscopy centres.There was a low proportion of pre-diagnosis and pre-treatment attrition in patients with presumptive and confirmed MDR-TB under programmatic conditions. However, the recording and reporting system did not detect all presumptive MDR-TB patients, highlighting the need to improve the system in order to prevent morbidity, mortality and transmission of MDR-TB in the community

Baseline socio-demographic and clinical characteristics of presumptive and confirmed MDR-TB patients in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 836].

<p>Baseline socio-demographic and clinical characteristics of presumptive and confirmed MDR-TB patients in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 836].</p

Characteristics of presumptive MDR-TB patients with pre-treatment attrition in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 33].

<p>“*”Row percentage</p><p>“**”Reference value to calculate relative risk</p><p>Characteristics of presumptive MDR-TB patients with pre-treatment attrition in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 33].</p

Characteristics of presumptive MDR-TB patients with pre-diagnosis attrition in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 139].

<p>“*”Row percentage</p><p>“**”Reference value to calculate relative risk</p><p>Characteristics of presumptive MDR-TB patients with pre-diagnosis attrition in BRAC supported regions of Bangladesh, July 2012- June 2014[N = 139].</p